Ensysce Biosciences Announces Completion Of $15 Million Convertible Note Financing
Amount Raised
$15 Million
Round Type
Convertible Note
Description
Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, announced today that it has completed its previously announced private placement under a securities purchase agreement with institutional investors (“Investors”) for senior secured convertible notes (the “Notes”) and warrants exercisable for Ensysce common stock (the “Warrants”) for an aggregate investment of $15 million. The final funding by the Investors of $10 million, prior to fees and offering expenses, occurred on November 5, 2021.
Quick answer
Ensysce Biosciences raised $15 Million in a Convertible Note round, dated November 8, 2021. Ensysce Biosciences is based in La Jolla, California, United States.
- How much did Ensysce Biosciences raise?
- Ensysce Biosciences raised $15 Million in a Convertible Note round on November 8, 2021.
- What does Ensysce Biosciences do?
- Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription..
- Where is Ensysce Biosciences based and how big is it?
- Ensysce Biosciences is based in La Jolla, California, United States. Fundz records about 12 employees.
- Who are the decision-makers at Ensysce Biosciences?
- Fundz holds 2 contacts at Ensysce Biosciences, including the Consultant, Fintechs. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Hardware around the same time
Companies in the same sectors as Ensysce Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Beeline Holdings raised an undisclosed amount (Series A) on December 9, 2021.
- Citizens Financial Group raised an undisclosed amount (Funding Round) on December 6, 2021.
- NB BANCORP raised $25M (Debt Financing) on December 21, 2021.
- Route 92 Medical raised $111M (Series E) on December 14, 2021.
- CoinMENA raised $9.5M (Seed) on November 10, 2021.
- Dhani Services Limited raised $157M (Funding Round) on October 20, 2021.
Who to call at Ensysce Biosciences, and when
A new round usually means Ensysce Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ensysce Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ensysce Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ensysce Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ensysce Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ensysce Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.